Health Center, Inc. (HCI) settles FTC charges, agrees to stop deceptive ads about “cure-all” health products

1142
SHARE

Health Center, Inc. (HCI) and its owner Peggy Pearce reached a settlement agreement with the Federal Trade Commission (FTC), which accused the defendants of violating consumer protection laws.

According to the FTC, HCI and Pearce agreed to a proposed order requiring them to stop their alleged deceptive advertising regarding three “cure-all” health and wellness products.

The defendants also consented to the order imposing an $8.62 million judgment, which will be partially suspended after paying $5,000 to the FTC. The suspension was due to their inability to fully pay the judgment. However, if the Commission later found that they misrepresented their financial condition, the full judgment will immediately become due.

FTC allegations against HCI and its owner

The FTC filed a complaint against HCI and Pearce for making false advertising claims that Rejuvi-Cell, Rejuvi-Sea, and Rejuvi-Stem could treat or cure serious diseases and health conditions such Alzheimer’s, cancer, diabetes, depression, obesity, and rheumatoid arthritis.